Uterine artery embolization versus total abdominal hysterectomy as a treatment modality: a comparative study of clinical outcomes and patient satisfaction in women with uterine fibroids ≤10 cm

Chuni Sangmu Bhutia; Pratibha Garg; Manohar Singh Rathore

doi:10.18203/2320-1770.ijrcog20263415

Authors

Chuni Sangmu Bhutia Department of Obstetrics and Gynecology, Gajra Raja Medical College, Gwalior, Madhya Pradesh, India
Pratibha Garg Department of Obstetrics and Gynecology, Gajra Raja Medical College, Gwalior, Madhya Pradesh, India
Manohar Singh Rathore Department of Obstetrics and Gynecology, Gajra Raja Medical College, Gwalior, Madhya Pradesh, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20263415

Keywords:

Hysterectomy, Minimally invasive treatment, Patient satisfaction, Uterine artery embolization, Uterine fibroids

Abstract

Background: Uterine fibroids are the most common benign tumours affecting women of reproductive age. Total abdominal hysterectomy (TAH) is the definitive treatment, while uterine artery embolization (UAE) is a minimally invasive alternative. This study compares clinical outcomes and patient satisfaction between UAE and TAH.

Methods: A prospective observational study including 30 women with symptomatic uterine fibroids ≤10cm. Patients were divided into two groups: UAE(n=15) and TAH (n=15). Follow-up was done at 3 months, 6 months and 1 year.

Results: UAE showed shorter operative time, reduced blood loss, less postoperative pain and shorter hospital stay compared with TAH. Fibroid reduction up to 60% at one year was observed in the UAE group. Psychological well-being improved in 80% of UAE patients and 75% of TAH patients.

Conclusions: UAE is a safe and effective minimally invasive alternative to hysterectomy for symptomatic fibroids ≤ 10cm with high patient satisfaction and faster recovery.

Metrics

Metrics Loading ...

References

Eltoukhi HM, Modi MN, Weston M, Armstrong AY, Stewart EA. The health disparities of uterine fibroid tumors for African American women: a public health issue. Am J Obstet Gynecol. 2014;210(3):194-9. DOI: https://doi.org/10.1016/j.ajog.2013.08.008

Donnez J, Dolmans MM. Uterine fibroid management: from the present to the future. Hum Reprod Update 2016;22(6):665-86. DOI: https://doi.org/10.1093/humupd/dmw023

Lee EJ, Park SJ, Kim SC, Kim Y, Joo JK. Effect and safety of diluted vasopressin injection on bleeding during robot-assisted laparoscopic myomectomy: a protocol for a randomised controlled pilot trial. BMJ Open. 2022;12(9):e056145. DOI: https://doi.org/10.1136/bmjopen-2021-056145

Park SJ, Kim SC, Kim Y, Joo JK, Lee EJ. Effect and safety of diluted vasopressin injection on bleeding control during robot-assisted laparoscopic myomectomy in reproductive women with uterine fibroids: a randomized controlled pilot trial (VALENTINE Trial). In Vivo. 2024;38(1):431-6. DOI: https://doi.org/10.21873/invivo.13456

Yang J, Fan X, Gao J, Li D, Xu Y, Chen G. Cost effectiveness analysis of total laparoscopic hysterectomy versus total abdominal hysterectomy for uterine fibroids in Western China: a societal perspective. BMC Health Serv Res. 2022;22(1):252. DOI: https://doi.org/10.1186/s12913-022-07644-9

Martin J, Bhanot K, Athreya S. Complications and reinterventions in uterine artery embolization for symptomatic uterine fibroids: a literature review and meta-analysis. Cardiovasc Intervent Radiol 2013;36(2):395-402. DOI: https://doi.org/10.1007/s00270-012-0505-y

Laughlin-Tommaso SK, Jacoby VL, Myers ER. Disparities in fibroid incidence, prognosis, and management. Obstet Gynecol Clin North Am 2017;44(1):81-94. DOI: https://doi.org/10.1016/j.ogc.2016.11.007

Vo NJ, Andrews RT. Uterine artery embolization: a safe and effective, minimally invasive, uterine-sparing treatment option for symptomatic fibroids. Semin Intervent Radiol. 2008;25(3):252-60. DOI: https://doi.org/10.1055/s-0028-1085923

Lara C, Lewis G. Does preoperative uterine artery embolization decrease blood loss during total abdominal hysterectomy for uterine fibroids? Am J Obstet Gynecol. 2024;230(4):S1180. DOI: https://doi.org/10.1016/j.ajog.2024.02.065

van der Kooij SM, Hehenkamp WJ, Volkers NA, Birnie E, Ankum WM, Reekers JA. Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5-year outcome from the randomized EMMY trial. Am J Obstet Gynecol 2010;203(2):105.e1-13. DOI: https://doi.org/10.1016/j.ajog.2010.01.049

Gonsalves C. Uterine artery embolization for treatment of symptomatic fibroids. Semin Intervent Radiol. 2008;25(4):369-77. DOI: https://doi.org/10.1055/s-0028-1103001

Psilopatis I, Fleckenstein FN, Collettini F, Can E, Frisch A, Gebauer B, et al. Short- and long-term evaluation of disease-specific symptoms and quality of life following uterine artery embolization of fibroids. Insights Imaging. 2022;13(1):106. DOI: https://doi.org/10.1186/s13244-022-01244-1

Anchan RM, Wojdyla D, Bortoletto P, Terry K, Disler E, Milne A, et al. A comparative analysis of health-related quality of life 1 year following myomectomy or uterine artery embolization: findings from the COMPARE-UF Registry. J Womens Health (Larchmt). 2023;32(4):423-33. DOI: https://doi.org/10.1089/jwh.2022.0133

Manyonda I, Belli AM, Lumsden MA, Moss J, McKinnon W, Middleton LJ, et al. Uterine-artery embolization or myomectomy for uterine fibroids. N Engl J Med 2020;383(5):440-51. DOI: https://doi.org/10.1056/NEJMoa1914735

Berkane N, Moutafoff-Borie C. Impact of previous uterine artery embolization on fertility. Curr Opin Obstet Gynecol. 2010;22(3):242-7. DOI: https://doi.org/10.1097/GCO.0b013e328338c179

Smith WJ, Upton E, Shuster EJ, Klein AJ, Schwartz LB. Patient satisfaction and disease-specific quality of life after uterine artery embolization. Am J Obstet Gynecol. 2004;190(6):1697-703. DOI: https://doi.org/10.1016/j.ajog.2004.02.043